Acacia Pharma Group PLC - Transparency Notification
THIS ANNOUNCEMENT CONTAINS REGULATED INFORMATION.
PUBLICATION RELATING TO A TRANSPARENCY NOTIFICATION
(ARTICLE 14, 1ST PARAGRAPH, OF THE LAW OF 2 MAY 2007 ON THE DISCLOSURE OF MAJOR HOLDINGS)
1. Summary of the notification
Cambridge, UK and Indianapolis, US – 05 March 2021, 09:00 CET: Acacia Pharma Group plc has received a transparency notification dated 02 March 2021 indicating that Coltrane Asset Management L.P. now holds, by virtue of the purchase of shares on 18 February 2021, 5.50% of the voting rights of the company. Coltrane has therefore crossed the threshold of 5%.
2. Content of notification
The notification dated 2 March 2021 contains the following information:
- Reason of the notification – acquisition or disposal of voting securities or voting rights
- Notification by – a parent undertaking or a controlling person
- Persons subject to the notification requirement:
Name |
Address (for legal entities) |
Mandeep Manku |
250 W 55th St 16C |
Coltrane Asset Management Holdings, Ltd |
94 Solaris Avenue |
Coltrane Asset Management, L.P. |
94 Solaris Avenue |
- Date on which the threshold is crossed – 18 February 2021
- Threshold that is crossed – 5%
- Denominator – 89,689,451
- Notified details:
A) Voting rights |
Previous notification |
After the transaction |
|||
|
# of voting rights |
# of voting rights |
% of voting rights |
||
Holders of voting rights |
|
Linked to securities |
Not linked to securities |
Linked to securities |
Not linked to securities |
Mandeep Manku |
|
0 |
0 |
0.00% |
0.00% |
Coltrane Asset Management, L.P. |
|
4,931,684 |
0 |
5.50% |
0.00% |
Subtotal |
|
4,931,684 |
|
5.50% |
|
|
TOTAL |
4,931,684 |
0 |
5.50% |
0.00% |
B) Voting rights |
After the transaction |
|||||
Holders of equivalent financial instruments |
Type of financial instrument |
Expiration date |
Exercise period or date |
# of voting rights that may be acquired if the instrument is exercised |
% of voting rights |
Settlement |
|
|
|
|
|
|
|
|
TOTAL |
|
|
0 |
0.00% |
|
|
Full chain of controlled undertakings through which the holding is effectively held:
- Coltrane Asset Management, L.P. is an investment advisor which manages funds and accounts which hold the shares reported in this filing.
- Coltrane Asset Management, L.P. can exercise the voting rights at its discretion, without any instruction from its clients.
- Coltrane Asset Management, L.P. is controlled by Coltrane Asset Management Holdings, Ltd, which is controlled by Mandeep Manku.
3. Miscellaneous
- This press release is available on Acacia Pharma Group plc’s website (https://acaciapharma.com/investors/regulatory-announcements)
- The notification may be found on Acacia Pharma Group plc’s website ((https://acaciapharma.com/investors/regulatory-announcements)
Contacts
Acacia Pharma Group plc |
International Media |
US Investors |
Media in Belgium and the Netherlands |
Acacia Pharma Group plc
The Officers’ Mess, Royston Road, Duxford, Cambridge, CB22 4QH, United Kingdom
Company number 9759376
Attachment